The rise of biomolecules (oligos, GLP-1, ADCs, etc.) complicates analytical workflows. Their analysis, whether in development or QC, requires controlling various attributes: identity, purity, structural integrity, etc. The choice of methods (CE, LC, UV, MS, etc.) can be challenging. This session will guide you in selecting appropriate solutions, presenting available approaches, their strengths, limitations, and application examples.
